Víctor A. Arrieta

发表

TOP2B Enzymatic Activity on Promoters and Introns Modulates Multiple Oncogenes in Human Gliomas

Atique U. Ahmed, A. Shilatifard, D. Brat, 2019, Clinical Cancer Research.

Myeloid Cell Classification and Therapeutic Opportunities Within the Glioblastoma Tumor Microenvironment in the Single Cell-Omics Era

C. James, A. Heimberger, A. Sonabend, 2022, Frontiers in Immunology.

Repurposing autophagy regulators in brain tumors

Deepak Kanojia, M. Lesniak, A. Cordero, 2022, International journal of cancer.

Central nervous system immune interactome is a function of cancer lineage, tumor microenvironment, and STAT3 expression

Daniel E. Winkowski, R. Verhaak, C. James, 2022, JCI insight.

Diagnosis of brain metastases in breast cancer patients resulting from neurological symptoms

M. Chávez-MacGregor, T. Wegman-Ostrosky, M. Granados-García, 2018, Clinical Neurology and Neurosurgery.

CD8+ T-cell–Mediated Immunoediting Influences Genomic Evolution and Immune Evasion in Murine Gliomas

R. Rabadán, P. Canoll, G. Rao, 2020, Clinical Cancer Research.

A Rare Case of Septic Arthritis of Lumbar Facet Joint with Epidural Abscess, and Bacterial Meningitis Caused by Methicillin-Sensitive Staphylococcus aureus

J. Mejia, Víctor A. Arrieta, Miguel Ángel Maldonado-Morán, 2018, Indian Journal of Neurosurgery.

B-cells Drive Response to PD-1 Blockade in Glioblastoma Upon Neutralization of TGFβ-mediated Immunosuppression

Mark W. Youngblood, P. Zhang, Junfei Zhao, 2023, Research square.

Recent advances in neoadjuvant therapy for breast cancer

D. Yee, D. Potter, Michael J Franklin, 2021, Faculty Reviews.

The Eclectic Nature of Glioma-Infiltrating Macrophages and Microglia

A. Heimberger, A. Sonabend, Hinda Najem, 2021, International journal of molecular sciences.

Ultrasound-mediated Delivery of Paclitaxel for Glioma: A Comparative Study of Distribution, Toxicity, and Efficacy of Albumin-bound Versus Cremophor Formulations

C. James, R. Stupp, C. Horbinski, 2019, Clinical Cancer Research.

Activation of 4-1BBL+ B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma

R. Stupp, C. Horbinski, A. Sonabend, 2020, The Journal of experimental medicine.

Can patient selection and neoadjuvant administration resuscitate PD-1 inhibitors for glioblastoma?

R. Rabadán, A. Sonabend, F. Iwamoto, 2019, Journal of neurosurgery.

The possibility of cancer immune editing in gliomas. A critical review

R. Rabadán, Junfei Zhao, A. Sonabend, 2018, Oncoimmunology.

IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM

C. Horbinski, A. Sonabend, I. Balyasnikova, 2023, Journal for ImmunoTherapy of Cancer.

Cancer Immunoediting in Gliomas: Recent Advances and Implications for Immunotherapy.

A. Sonabend, C. Lee-Chang, P. Shah, 2020, Journal of cellular immunology.

Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment

D. Brat, R. Stupp, A. Heimberger, 2023, The Journal of clinical investigation.

ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma

D. Brat, R. Stupp, R. Rabadán, 2021, Nature Cancer.

Local Administration of Therapies and Drug Delivery Strategies for the Treatment of Gliomas

A. Sonabend, Daniel Y. Zhang, Víctor A. Arrieta, 2020 .

Cervical Intramedullary Schwannoma: Case Report and Review of the Literature

Víctor A. Arrieta, Bernardo Cacho Díaz, José Omar Navarro Fernández, 2018, Case Reports in Neurology.

CD8+ T-cell–Mediated Immunoediting Influences Genomic Evolution and Immune Evasion in Murine Gliomas

R. Rabadán, P. Canoll, G. Rao, 2019, Clinical Cancer Research.

Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial.

Atique U. Ahmed, R. Stupp, M. Tate, 2021, The Lancet. Oncology.

Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade

P. Hsu, P. Zhang, Junfei Zhao, 2023, Nature Communications.

Repeated blood-brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial.

R. Stupp, A. Sonabend, I. Helenowski, 2023, The Lancet. Oncology.

Translocon-associated protein subunit SSR3 determines and predicts susceptibility to paclitaxel in breast cancer and glioblastoma.

Atique U. Ahmed, P. Hsu, R. Stupp, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Delivering albumin-bound paclitaxel across the blood-brain barrier for gliomas

R. Stupp, A. Sonabend, Andrew Gould, 2021, Oncotarget.